Login / Signup

Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs.

Chiu Wai Shirley ChanCheong Kay TeoPhilip Hei LiKui Kai LauChak Sing LauHo Yin Chung
Published in: Therapeutic advances in musculoskeletal disease (2021)
SpA is an independent CVS risk factor. Anti-tumor necrosis factor (TNF) drugs were associated with a reduced CVS risk in these patients.
Keyphrases
  • rheumatoid arthritis
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • risk factors
  • newly diagnosed
  • peritoneal dialysis
  • prognostic factors
  • disease activity
  • ankylosing spondylitis
  • patient reported